1. Large artery ischemic stroke in severe COVID-19

   • Fernando Sierra-Hidalgo
   • Nuria Muñoz-Rivas
   • Eva Martínez-Acebes

   Letter to the Editors 27 June 2020 Pages: 3441 - 3443

2. Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies

   • Giovanni Palermo
   • Eleonora Del Prete
   • Roberto Ceravolo

   Original Communication 27 June 2020 Pages: 3444 - 3456

   

3. What has caused the fall in stroke admissions during the COVID-19 pandemic?

   • Richard Perry
   • Azra Banaras
   • Robert Simister

   Letter to the Editors 29 June 2020 Pages: 3457 - 3458

   

4. Transverse myelitis related to COVID-19 infection

   • Alexandros Zachariadis
   • Anca Tulbu
   • Gabriella Di Virgilio

   Letter to the Editors 29 June 2020 Pages: 3459 - 3461

   

5. COVID-19 reveals influence of physical activity on symptom severity in hereditary spastic paraplegia

   • Lotte van de Venis
   • Bart P. C. van de Warrenburg
   • Jorik Nonnekes

   Letter to the Editors 07 July 2020 Pages: 3462 - 3464

   

6. Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?

   • Vittorio Mantero
   • Andrea Rigamonti
   • Andrea Salmaggi

   Letter to the Editors 07 July 2020 Pages: 3465 - 3466

7. Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices

   • Farrah J. Mateen
   • Shawheen Rezaei
   • Andre Vogel

   Original Communication 07 July 2020 Pages: 3467 - 3475

   

8. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19

   • Markus Ameres
   • Susanne Brandstetter
   • Sven Wellmann

   Letter to the Editors Open access 09 July 2020 Pages: 3476 - 3478

   

9. The effect of transcranial direct current stimulation on upper limb motor performance in Parkinson’s disease: a systematic review

   • Michael William Simpson
   • Margaret Mak

   Review 23 May 2019 Pages: 3479 - 3488

10. Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis

    • Huihui Li
    • Fengli Hu
    • Kai Li

    Review 25 May 2019 Pages: 3489 - 3498

    

11. Long-term efficacy of immunoglobulins in small fiber neuropathy related to Sjögren’s syndrome

    • Taylor Pindi Sala
    • Mona Villedieu
    • Cristina Belizna

    Original Communication 01 July 2020 Pages: 3499 - 3507

12. Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study

    • Gianna C. Riccitelli
    • Elisabetta Pagani
    • Maria A. Rocca

    Original Communication 02 July 2020 Pages: 3508 - 3517

    

13. Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity

    • Anne-Laure Kaminsky
    • Abdou Yacoubou Omorou
    • Guillaume Mathey

    Original Communication 02 July 2020 Pages: 3518 - 3527

    

14. Neurogenic calf amyotrophy with CK elevation by entrapment radiculopathy; clinical, radiological, and pathological analyses of 18 cases

    • Makoto Shibata
    • Hiroo Kasahara
    • Yoshio Ikeda

    Original Communication 03 July 2020 Pages: 3528 - 3540

    

15. Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis: an evaluation of four automated methods against manual reference segmentations in a multi-center cohort

    • Alexandra de Sitter
    • Tom Verhoeven
    • the MAGNIMS Study Group

    Original Communication Open access 03 July 2020 Pages: 3541 - 3554

    

16. Cell-based assays for the detection of MOG antibodies: a comparative study

    • Matteo Gastaldi
    • Silvia Scaranzin
    • Diego Franciotta

    Original Communication 04 July 2020 Pages: 3555 - 3564

    

17. Treatment of MOG antibody associated disorders: results of an international survey

    • D. H. Whittam
    • V. Karthikeayan
    • A. Jacob

    Original Communication 04 July 2020 Pages: 3565 - 3577

    

18. Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE

    • Marta Gromicho
    • Ana Margarida Coutinho
    • Mamede de Carvalho

    Original Communication 07 July 2020 Pages: 3578 - 3592

    

19. Disease progression but not physical state per se determines mental wellbeing in ALS

    • Cynthia R. Vázquez Medrano
    • Helena E. A. Aho-Özhan
    • Dorothée Lulé

    Original Communication Open access 08 July 2020 Pages: 3593 - 3601

    

20. Clinical and radiological differences between patients with probable cerebral amyloid angiopathy and mixed cerebral microbleeds

    • Ulf R. Jensen-Kondering
    • Caroline Weiler
    • Nils G. Margraf

    Original Communication Open access 08 July 2020 Pages: 3602 - 3608

    

21. Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis

    • Christian Lunetta
    • Andrea Lizio
    • Jonica Campolo

    Original Communication 08 July 2020 Pages: 3609 - 3616

    

22. Yield of the PMP22 deletion analysis in patients with compression neuropathies

    • Vukan Ivanovic
    • Marija Brankovic
    • Stojan Peric

    Original Communication 08 July 2020 Pages: 3617 - 3623

23. Deep brain stimulation reduces (nocturnal) dyskinetic exacerbations in patients with ADCY5 mutation: a case series

    • Ana Luísa de Almeida Marcelino
    • Tina Mainka
    • Andrea A. Kühn

    Original Communication Open access 09 July 2020 Pages: 3624 - 3631

24. Risk incidence of fractures and injuries: a multicenter video-EEG study of 626 generalized convulsive seizures

    • Katharina Frey
    • Johann Philipp Zöllner
    • Adam Strzelczyk

    Original Communication Open access 10 July 2020 Pages: 3632 - 3642

    

25. Behr syndrome and hypertrophic cardiomyopathy in a family with a novel UCHL1 deletion

    • Grace McMacken
    • Hanns Lochmüller
    • Rita Horvath

    Original Communication Open access 12 July 2020 Pages: 3643 - 3649

    

26. 24-h polysomnographic recordings and electrophysiological spectral analyses from a cohort of patients with chronic disorders of consciousness

    • Raechelle M. Gibson
    • Laura B. Ray
    • Stuart M. Fogel

    Original Communication 15 July 2020 Pages: 3650 - 3663

    

27. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera

    • Emilien Delmont
    • Alexandre Brodovitch
    • José Boucraut

    Original Communication 16 July 2020 Pages: 3664 - 3672

    

28. Prodromal Parkinson disease in patients with idiopathic hyposmia

    • Paula Marrero-González
    • Alex Iranzo
    • Joaquim Mullol

    Original Communication 16 July 2020 Pages: 3673 - 3682

29. Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study

    • Vivien Li
    • Jalesh N. Panicker
    • Jeremy Chataway

    Original Communication Open access 16 July 2020 Pages: 3683 - 3688

    

30. Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype

    • Stefano Zoccolella
    • Antonella Mastronardi
    • Isabella Laura Simone

    Original Communication Open access 16 July 2020 Pages: 3689 - 3695

    

31. Cerebrospinal fluid opening pressure in clinical practice – a prospective study

    • Siri Hylleraas Bø
    • Christofer Lundqvist

    Original Communication Open access 17 July 2020 Pages: 3696 - 3701

    

32. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications

    • Roberto D’Angelo
    • Elisa Boschetti
    • Rita Rinaldi

    Original Communication 18 July 2020 Pages: 3702 - 3710

    

33. The neuro-otology of Susac syndrome

    • Todd A. Hardy
    • Rachael L. Taylor
    • G. Michael Halmagyi

    Original Communication 21 July 2020 Pages: 3711 - 3722

    

34. The importance of physical activity to preserve hippocampal volume in people with multiple sclerosis: a structural MRI study

    • Alon Kalron
    • Shay Menascu
    • Anat Achiron

    Original Communication 22 July 2020 Pages: 3723 - 3730

35. Direct thrombectomy for stroke in the presence of absolute exclusion criteria for thrombolysis

    • Manuel Cappellari
    • Giovanni Pracucci
    • Danilo Toni

    Original Communication 25 July 2020 Pages: 3731 - 3740

36. Oxidative stress biomarkers in Fabry disease: is there a room for them?

    • C. Simoncini
    • S. Torri
    • Michelangelo Mancuso

    Original Communication Open access 27 July 2020 Pages: 3741 - 3752

    

37. Parity and disability progression in relapsing–remitting multiple sclerosis

    • Anat Achiron
    • Alon Ben-David
    • for the Israeli Multiple Sclerosis Pregnancy Study Group (IMSPSG)

    Original Communication 28 July 2020 Pages: 3753 - 3762

    

38. Ocular lateral deviation with brief removal of visual fixation differentiates central from peripheral vestibular syndrome

    • Jorge C. Kattah
    • Shervin Badihian
    • David S. Zee

    Original Communication 28 July 2020 Pages: 3763 - 3772

    

39. Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report

    • Serena Marita Lazzarin
    • Miryam Cannizzaro
    • Massimo Filippi

    Letter to the Editors 03 November 2020 Pages: 3773 - 3775

    

40. Emerging themes in idiopathic intracranial hypertension

    • Olivia Grech
    • Susan P. Mollan
    • Alexandra J. Sinclair

    Neurological Update Open access 22 July 2020 Pages: 3776 - 3784

    

41. Challenges in predicting traumatic brain injury outcomes

    • Mo Hu
    • Ineta Zobina
    • Eleanor Marsh

    Journal club 04 November 2020 Pages: 3785 - 3787

42. Izydor Fajersztajn-Krzemicki (1867–1935)

    • Sławomir Gonkowski
    • Jaroslaw Calka

    Pioneers in Neurology Open access 31 October 2019 Pages: 3788 - 3789